Eleanor Malone
@ScripEleanor
Followers
2K
Following
75
Media
94
Statuses
3K
Editor in Chief, Commercial Insights, Citeline - Scrip, In Vivo, Generics Bulletin - covering biopharma news and analysis. All views are my own.
London
Joined July 2011
RT @SarahKarlin: heading to the Senate this afternoon for the Bernie-Insulin makers-PBM showdown.
0
1
0
A group of us @citeline and @norstella are taking part in #RaceforLife in memory of our colleague Maureen Kenny - @scripregmaureen - and we would love to raise as much as possible for cancer research.
0
0
1
My brilliant, funny, lovely dad.
Andrew Malone obituary
0
0
5
We're hiring! We need a US reporter with experience covering #biopharma to join our global team of expert journalists at @PharmaScrip. If you can bring expert analysis to industry events and trends, apply here:
0
5
2
RT @INVIVOnow: Are you our new Features Writer? . Know someone who might be?. Find our latest available role and apply now: .
0
3
0
Journalists! We are looking for an enterprising investigative reporter to build a beat around drug pricing, reimbursement and market strategy for subscribers to @PharmaScrip's analytical news and insights service (part of the @pharma_intell suite).
0
0
1
We are looking for a feature and interview writer to join @INVIVOnow as part of the @pharma_intell family
0
0
0
We're hiring on @PharmaScrip and @INVIVOnow for great journalists to dig deep into #pharma issues like drug pricing, business strategy and scientific innovation. Apply here: &
0
0
0
And a very warm welcome To Chloe - we're so excited you've joined @DaveGenerics and our @Genericbulletin team!.
1
0
3
RT @awmcconaghie: A very warm @PharmaScrip welcome to our new colleague @Ayisha_Sharma97! Great to have you on our team of biopharma journa….
0
5
0
RT @PinkSheetDenise: @dgingery analyzes Califf's previous Senate confirmation history to preview what might happen now.
0
1
0
Are you an expert in US pharma pricing, reimbursement & markets? Can you write compelling news/analysis for pharma decision makers? We want to recruit a journalist to build a beat around commercial strategy, drug pricing and the payer environment for Scrip
0
2
2
There's still time to sign up for the @Pharma_Intell three-part panel discussion series on cell and gene therapies. First one starts in 90 mins, on novel development strategies for clinical trials
0
0
0
RT @scripanjug: Lot of plain speaking here by NIH chief & Hamburg. WHO efforts/role valuable/critical but very difficult for it to be drive….
0
1
0
Check out our new 2021 line-up of 30 rising leaders in pharma, biotech & health tech just published in @INVIVOnow @Pharma_Intell.
0
2
1
Join @INVIVOnow on May 18 for a panel discussion on leadership in times of uncertainty and upheaval, with Mark Reisenauer from @AstellasUS, Albireo's Ron Cooper, Semi Trotto from Thrive Earlier Detection and Catherine Owen, @bmsnews
0
1
1
RT @CitelineIanL: The 2021 #PharmaRnDReview is coming soon! Did COVID-19 hold back R&D pipeline expansion? Not a bit of it - our data shows….
0
1
0
Scrip Asks…What Does 2021 Hold For Biopharma? Part 5: Business Environment And Strategy FREE TO VIEW - the final part of our series, in which 200+ execs/experts shared with @PharmaScrip their predictions. Expect deals aplenty. .
0
0
0
17 ways in which the pandemic has changed things for the biopharma sector: Free to view. Scrip Asks…What Does 2021 Hold For Biopharma? Part 2: COVID-19 Shock Waves And Silver Linings
0
0
0